Warfarin Sensitivity Test Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Warfarin Sensitivity Test Market Analysis
The warfarin sensitivity test market is expected to register a healthy CAGR during the forecast period. The major contributing factors responsible for driving the market growth are the increasing burden of blood-related disorders and technological advancements in the field.
- Thrombosis refers to the condition wherein a clot is formed in a blood vessel. According to the International Society of Thrombosis and Haemostasis, around one out of four people die due to thrombosis globally each year.
- Furthermore, according to the Center for Disease Control and Prevention, in 2020, between 60,000 to 100,000 people died due to thrombosis in the United States, and approximately 5 % to 8 % of the population has a genetic defect.
- The treatment for these disorders involves warfarin drug, and hence, the warfarin sensitivity test market is expected to witness high growth over the forecast period.
Warfarin Sensitivity Test Market Trends
This section covers the major market trends shaping the Warfarin Sensitivity Test Market according to our research experts:
Genetic Testing Segment is Expected to Hold a Major Market Share in the Warfarin Sensitivity Test Market
- Warfarin is the most widely used anticoagulant for the treatment of thrombosis. However, the sensitivity toward it can cause serious complications, such as heart stroke, peptic diseases, and uncontrolled blood pressure, among others. The sensitivity depends upon the number of copies of the altered gene in the cell. According to the study published by BMC Medicine, in 2019, the accurate dose of warfarin was determined in the patients with the help of a point-of-care genotyping information approach.
- In addition, according to the data published by the International Society on Thrombosis and Haemostasis Inc., every year, the United States experiences an approximate number of 100,000 to 300,000 deaths related to venous thromboembolism, while in Europe, it has been observed to be at approximately 554,000 deaths.
- Furthermore, according to the National Institute of Health, approximately 2 million people have been prescribed warfarin annually, and around 35,000 to 45,000 people visit the hospital for adverse events due to warfarin. Therefore, the aforementioned factors are expected to fuel the market growth in this segment.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global warfarin sensitivity test market due to the rise in the aging population and the associated bleeding disorders. The geriatric population is at a higher risk of warfarin sensitivity. The elder population has decreased metabolic activities, which alter the pharmacokinetics of the drug, and hence, higher sensitivity is observed in the geriatric population. According to the data published by the US Census Bureau, in 2018, there were around 52 million people living at the age of 65 and above. Furthermore, according to the Center for Disease Control and Prevention, at least 900,000 people are likely to suffer from venous thromboembolism. Hence, these factors are expected to propel the warfarin sensitivity test market growth.
Warfarin Sensitivity Test Industry Overview
The companies have been constantly focused on developing new products related to warfarin sensitivity test, in order to grow their presence in the market. For instance, in 2019, Eurolyser DIagnostica Gmbh added bidirectional connectivity to the 'CUBE' series to enhance the data management software. Some of the companies, which are currently dominating the market, are AutoGenomics, Abbott, Eurolyser Diagnostica GmbH, TrimGen Corporation, Generi Biotech, F. Hoffmann-La Roche Ltd, Acon Laboratories Inc., and Coagu Sense Inc.
Warfarin Sensitivity Test Market Leaders
-
Abbott
-
Hoffmann-La Roche Ltd.
-
Eurolyser Diagnostica GmbH
-
AutoGenomics
-
Trimgen Corporation
*Disclaimer: Major Players sorted in no particular order
Warfarin Sensitivity Test Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Growing Burden of Blood-related Disorders
-
4.2.2 Rising Geriatric Population
-
-
4.3 Market Restraints
-
4.3.1 Stringent Regulatory Framework
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product Type
-
5.1.1 Instrument
-
5.1.2 Consumable
-
-
5.2 By Test Type
-
5.2.1 Genetic
-
5.2.2 Non-genetic
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle East & Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle East & Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott Laboratories
-
6.1.2 Acon Laboratories Inc.
-
6.1.3 AutoGenomics
-
6.1.4 Coagu Sense Inc.
-
6.1.5 Eurolyser Diagnostica GmbH
-
6.1.6 F. Hoffmann-La Roche Ltd
-
6.1.7 Generi Biotech
-
6.1.8 TrimGen Corporation
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Warfarin Sensitivity Test Industry Segmentation
Warfarin sensitivity is a condition wherein the person is sensitive to warfarin, which is an anti-coagulant and works as a blood thinner. The warfarin sensitivity test is performed for the determination of one's tolerability toward warfarin, and thus, helps in selecting the appropriate dose. The warfarin sensitivity test market is segmented by product type, test type, and geography.
| By Product Type | |
| Instrument | |
| Consumable |
| By Test Type | |
| Genetic | |
| Non-genetic |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Warfarin Sensitivity Test Market Research FAQs
What is the current Wardarin Sensitivity Test Market size?
The Wardarin Sensitivity Test Market is projected to register a CAGR of 5.10% during the forecast period (2024-2029)
Who are the key players in Wardarin Sensitivity Test Market?
Abbott, Hoffmann-La Roche Ltd., Eurolyser Diagnostica GmbH, AutoGenomics and Trimgen Corporation are the major companies operating in the Wardarin Sensitivity Test Market.
Which is the fastest growing region in Wardarin Sensitivity Test Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Wardarin Sensitivity Test Market?
In 2024, the North America accounts for the largest market share in Wardarin Sensitivity Test Market.
What years does this Wardarin Sensitivity Test Market cover?
The report covers the Wardarin Sensitivity Test Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Wardarin Sensitivity Test Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Wardarin Sensitivity Test Industry Report
Statistics for the 2024 Wardarin Sensitivity Test market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Wardarin Sensitivity Test analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
